| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/18/2006 | US20060106048 Furoisoquinoline derivative and use thereof |
| 05/18/2006 | US20060106015 Novel use of benzothiazole derivatives |
| 05/18/2006 | US20060105988 Antipruritic composition for external use on skin |
| 05/18/2006 | US20060105987 Sulfur-containing phospholipid derivatives |
| 05/18/2006 | US20060105957 Loop peptide and TGFalpha for stimulating stem cell proliferation and migration |
| 05/18/2006 | US20060105423 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors |
| 05/18/2006 | US20060105048 Remedy |
| 05/18/2006 | US20060105031 Accelerating recovery from trauma |
| 05/18/2006 | US20060104998 e.g. 2-Amino-4-(3-bromo-4,5-dimethoxyphenyl)-3-cyano-7-methyl-4H-pyrrolo [2,3-h]chromene; antiproliferative, antitumor, anticarcinogenic agent |
| 05/18/2006 | US20060104974 CD147 binding molecules as therapeutics |
| 05/18/2006 | US20060104947 Remedy for pemphigoid |
| 05/18/2006 | US20060104943 Vaccine comprising il-13 and an adjuvant |
| 05/18/2006 | US20060104942 Anticholesterol agents; anticholesterol agents; cardiovascular disorders; mixture of colony stimulating factor and hepatocyte growth factor |
| 05/18/2006 | DE19608751B4 Verwendung eines Adeno-assoziierten Virus-Vektors zur Steigerung der Immunogenität von Zellen Using an adeno-associated virus vector to enhance the immunogenicity of cells |
| 05/18/2006 | CA2587667A1 Imine compound |
| 05/18/2006 | CA2587369A1 Mutant interferon .alpha. proteins and use thereof |
| 05/18/2006 | CA2587192A1 Imidazo[1 , 2-a] pyrazin-8-ylamines useful as modulators of kinase activity |
| 05/18/2006 | CA2585927A1 Polypeptides that bind baff and/or april |
| 05/17/2006 | EP1657307A1 Oligonucleotides that induce the secretion of GM-CSF |
| 05/17/2006 | EP1657247A1 Steroidal compounds for inhibiting steroid sulphotase |
| 05/17/2006 | EP1657233A1 Lipoxin compounds |
| 05/17/2006 | EP1656952A2 Polymer conjugates of interferon beta-1A and uses thereof |
| 05/17/2006 | EP1656949A1 Use of alpha-1 antitrypsin for the preparation of medicaments for the treatment of fibromyalgia |
| 05/17/2006 | EP1656936A1 Macrophage activation inhibitor |
| 05/17/2006 | EP1656376A1 Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases |
| 05/17/2006 | EP1656373A2 Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and use of same as chemokineantagonists |
| 05/17/2006 | EP1656372A2 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases |
| 05/17/2006 | EP1656123A2 Anti-candida agents for the treatment of prion diseases |
| 05/17/2006 | EP1423391B1 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases |
| 05/17/2006 | EP1387660A4 Use of 3-position cyclosporin derivatives for hair growth |
| 05/17/2006 | EP1362047B1 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 05/17/2006 | EP1345929B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345927B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345926B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345925B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1330293B1 Controlled release composition comprising lactic acid polymer, and method of producing the same |
| 05/17/2006 | EP1317452B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317447B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1265616B1 Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate |
| 05/17/2006 | EP1231983B1 Combination of dhea and calcitonin for the treatment of subnormal bone mineral density |
| 05/17/2006 | EP1204652B1 Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 05/17/2006 | EP1141235B1 (bifidobacterium) in the treatment of inflammatory disease |
| 05/17/2006 | EP1115372B1 Fast dissolving orally consumable films |
| 05/17/2006 | EP1114035B1 Quinazoline derivatives and pharmaceutical applications thereof |
| 05/17/2006 | EP1113818B1 METHODS OF TREATING IgE-ASSOCIATED DISORDERS AND COMPOSITIONS FOR USE THEREIN |
| 05/17/2006 | EP1035866B1 Mixed lipopeptide micelles for inducing an immune response and their therapeutic uses |
| 05/17/2006 | EP0807124B1 Monoclonal antibody against flt4 receptor tyrosine kinase and its use in diagnosis and therapy |
| 05/17/2006 | EP0777490B1 Mutant enterotoxin effective as a non-toxic oral adjuvant |
| 05/17/2006 | CN1774635A Anti-epileptogenic agents |
| 05/17/2006 | CN1774444A Novel derivatives of androstane and androstene with ascorbic acid and use thereof in treating or preventing various conditions, diseases, and disorders |
| 05/17/2006 | CN1774440A Benzoxepino-11-piperidylidene compounds and process for production thereof |
| 05/17/2006 | CN1774428A M-stage kinesin inhibitor |
| 05/17/2006 | CN1774259A Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 05/17/2006 | CN1772897A Cell factor with several functions |
| 05/17/2006 | CN1772768A Extracellular polysaccharide sulfate of nitzschia closterium and its prepn and application |
| 05/17/2006 | CN1772765A Bionic affinity purifying process of interleukin I natural agonist |
| 05/17/2006 | CN1772733A Cyanopyrrolidine derivatives |
| 05/17/2006 | CN1772295A Application of cysteamine and its derivative in preparing medicine for raising potency of vaccine antibody |
| 05/17/2006 | CN1772268A Medicine composition for raising immunity and its prepn and application |
| 05/17/2006 | CN1772198A Prepn process of micron Yin-nourishing hypoglycemic milk |
| 05/17/2006 | CN1772197A Prepn process of micron Yin-nourishing hypoglycemic medicine granule, capsule and tablet |
| 05/17/2006 | CN1772170A Glabrous greenbrier total saponin extract and its prepn and use |
| 05/17/2006 | CN1772097A Prepn process of micron fatigue eliminating Chinese medicine oral liquid |
| 05/17/2006 | CN1772035A Freeze dried ginseng-astragalus powder for injection to strengthen body's resistance and its prepn |
| 05/17/2006 | CN1771984A New use of extracellular polysaccharide of halophilous aphanothece |
| 05/17/2006 | CN1256334C Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derilatives as IP antagonists |
| 05/17/2006 | CN1256147C CD8 as inhibitor of cellular immune system |
| 05/17/2006 | CN1256134C Medicinal composition for treating rheumatoid |
| 05/17/2006 | CN1256106C Medicinally health-care powder made of ganoderma and lentinan |
| 05/16/2006 | US7045660 [di(ether or thioether)heteroaryl or fluoro substituted aryl] compound or an N-oxide thereof or a salt thereof, useful for inhibiting the production or physiological effects of TNF in treatment of a patient suffering from a disease state associated with a detrimental excess of tumor necrosis factor |
| 05/16/2006 | US7045658 prophylaxis and treatment of respiratory diseases; phenethanolamine derivatives |
| 05/16/2006 | US7045626 Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-CD23 |
| 05/16/2006 | US7045576 Adjuvants and copolymer compositions |
| 05/16/2006 | US7045529 Imidazopyrimidinyl and imidazopyri dinyl derivatives |
| 05/16/2006 | US7045525 Use of (R)-peniciclovir triphosphate for the manufacture of a medicament for the treatment of viral diseases |
| 05/16/2006 | US7045521 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents |
| 05/16/2006 | US7045520 Opioid receptor active compounds |
| 05/16/2006 | US7045509 Proteins and nucleic acids encoding same |
| 05/16/2006 | US7045507 Substituted tetracycline compounds as synergistic antifungal agents |
| 05/16/2006 | US7045505 Isolation nucleic acids; genetic engineering; diagnosis, therapy, prevention hematopoietic, nervous system disorders |
| 05/16/2006 | US7045500 Comprises peptide with heparin and/or lipopolysaccharide binding activity for use as treatment of endotoxic shock and endometriosis, anticoagulant, angiogenesis inhibitor, antiproliferative agent and contraceptive |
| 05/16/2006 | US7045498 Soluble Zcytor11 cytokine receptors |
| 05/16/2006 | US7045353 Determining preferential gene expression pattern in embryonic cells; obtain cells, monitor gene expresion products, incubate with animal growth regulators, monitor gene expresion pattern and differentiation in cells |
| 05/16/2006 | US7045345 G-coupled receptor showing selective affinity for ATP |
| 05/16/2006 | US7045335 Immunotherapy; genetic engineering; anticancer agents |
| 05/16/2006 | US7045299 Digestive diseases; amino acid sequence 20 or 21; specific to orphan receptor protein ZAQ |
| 05/16/2006 | US7045143 Mixture of lecithin and fatty acid; antiinflammatory agents; diseases of lipid metabolism; immunology disorders |
| 05/16/2006 | US7045140 Therapeutic delivery of carbon monoxide |
| 05/16/2006 | US7045118 Delivery of compounds for the treatment of migraine through an inhalation route |
| 05/16/2006 | CA2192797C Indolinone compounds for the treatment of disease |
| 05/11/2006 | WO2006050480A2 Substituted pyridines with activity on syk kinase |
| 05/11/2006 | WO2006049498A1 Means and methods for isolating and/or identifying a target molecule |
| 05/11/2006 | WO2006049286A1 Preventive/remedy for allergic diseases |
| 05/11/2006 | WO2006049250A1 Aqueous eye drops with accelerated intraocular migration |
| 05/11/2006 | WO2006049215A1 Combination drug for treating autoimmune disease |
| 05/11/2006 | WO2006048862A2 The use of a protease or a protease inhibitor for the manufacture of medicaments |
| 05/11/2006 | WO2006047954A1 The method of obtaining and applying the materials for autoantigen immunological recognition |
| 05/11/2006 | WO2006027685A3 Glycosylceramide adjuvant for saccharide antigens |
| 05/11/2006 | WO2005051317A3 Substituted imidazo ring systems and methods |
| 05/11/2006 | WO2005018551A3 Oxime substituted imidazo-containing compounds |